Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-Drug Conjugates.

Bioconjugate chemistry·2015
Same author

A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO.

Nanoscale·2015
Same author

Folding Up of Gold Nanoparticle Strings into Plasmonic Vesicles for Enhanced Photoacoustic Imaging.

Angewandte Chemie (International ed. in English)·2015
Same author

Temporal-spatially transformed synthesis and formation mechanism of gold bellflowers.

Nanoscale·2015
Same author

Photoacoustic and Colorimetric Visualization of Latent Fingerprints.

ACS nano·2015
Same author

Virus-mimetic nanovesicles as a versatile antigen-delivery system.

Proceedings of the National Academy of Sciences of the United States of America·2015

Related Experiment Video

Updated: May 2, 2026

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
12:24

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Published on: July 17, 2012

13.2K

Integrin targeting for tumor optical imaging.

Yunpeng Ye1, Xiaoyuan Chen

  • 1National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Health (NIH), Bethesda, MD.

Theranostics
|May 7, 2011
PubMed
Summary

Optical imaging agents targeting integrins show promise for noninvasive tumor detection and therapy. Researchers are developing novel agents for enhanced cancer imaging and drug discovery.

Keywords:
multifunctional probesmultivalent RGD peptidesnanoparticle-based optical agents.near-infrared fluorescenceoptical imaging

More Related Videos

In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy
05:08

In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy

Published on: September 11, 2013

10.4K
Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

15.5K

Related Experiment Videos

Last Updated: May 2, 2026

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
12:24

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Published on: July 17, 2012

13.2K
In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy
05:08

In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy

Published on: September 11, 2013

10.4K
Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

15.5K

Area of Science:

  • Biomedical Imaging
  • Molecular Imaging
  • Oncology

Background:

  • Optical imaging offers noninvasive, sensitive, real-time molecular detection with advantages like cost-effectiveness and safety.
  • Integrin receptors are key targets for tumor optical imaging, with significant preclinical advances in the past decade.
  • Optical imaging complements other modalities like PET, SPECT, and MRI.

Purpose of the Study:

  • To review the development and evaluation of integrin-targeting agents for optical tumor imaging in preclinical models.
  • To highlight advancements in constructing diverse agents, including conjugates and nanoparticles, for integrin targeting.
  • To discuss the role of these agents in understanding cancer biology and guiding anticancer drug discovery.

Main Methods:

  • Review of literature on integrin-targeting agents for optical tumor imaging.
  • Focus on near-infrared fluorescent dye-RGD peptide conjugates, multivalent analogs, and nanoparticle conjugates.
  • Inclusion of agents targeting integrin subtypes αvβ3, α4β1, and α3.

Main Results:

  • Development of various integrin-targeting optical agents, including RGD peptide conjugates and nanoparticles.
  • Demonstration of promising in vitro and in vivo efficacy for tumor optical imaging.
  • Identification of multifunctional agents capable of multiplexing imaging and therapy (theranostics).

Conclusions:

  • Integrin-targeted optical agents significantly advance cancer biology understanding and drug discovery.
  • Multifunctional nanoparticle-based agents offer theranostic potential for simultaneous imaging and targeted therapy.
  • Continued development of novel integrin-based optical agents promises improved clinical cancer detection, diagnosis, and therapy.